How does gut microbiota affect acute pancreatitis?

The Importance of Gut Microbiota in Acute Pancreatitis A potentially fatal inflammatory condition known as acute pancreatitis is typically brought on by excessive alcohol consumption or gallstones. Although many patients survive the acute episode, a significant number develop long-term complications, such as exocrine pancreatic insufficiency, recurrent acute pancreatitis, diabetes mellitus, chronic pancreatitis, or pancreatic cancer. Opportunities for early risk stratification and prevention are limited as a result of the incomplete understanding of the biological mechanisms that drive these late complications. Profiling the microbiota and predicting long-term outcomes In this prospective multicentre study, researchers analysed gut microbiota data from 277 patients with acute pancreatitis across 15 European pancreatic centres.  Within 72 hours of hospital admission, buccal and rectal swabs were collected and analyzed using Oxford Nanopore sequencing, which enabled species-level bacterial identification. After being discharged, patients were monitored for a median of 2.8 years. Patients who later developed post-discharge mortality, recurrent acute pancreatitis, or diabetes mellitus showed significantly different compositions of the gut microbiota (p = 0.04). In the matched cohort, a ridge regression model with 11 bacterial species predicted diabetes mellitus after discharge with an area under the receiver operating characteristic curve of 94.8% and 86.2%, respectively. With a positive predictive value of 66.6% and a negative predictive value of 96%, the model was accurate to 95 percent. Clinical Implications and Future Directions
 Based on these findings, it could be possible to identify patients who are at a high risk for long-term complications following acute pancreatitis by profiling their gut microbiota before they are admitted to the hospital. Importantly, the associations remained unaffected by age, sex, antibiotic use, smoking status, or severity of pancreatitis. The findings raise the possibility that metabolic pathways driven by the microbiota directly influence disease progression and metabolic dysfunction. These findings are being validated and the possibility of reducing long-term morbidity through targeted interventions or microbiota-based monitoring is being investigated in ongoing global follow-up studies.